Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[In search for general PCR targets for minimal residual disease (MRD) studies in acute myeloid leukemia (AML), Wilms' tumor gene 1 (WT1) expression was assessed by real-time RT-PCR relative to the control gene ABL in 569 archived samples of AML patients (pts).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[In search for general PCR targets for minimal residual disease (MRD) studies in acute myeloid leukemia (AML), Wilms' tumor gene 1 (WT1) expression was assessed by real-time RT-PCR relative to the control gene ABL in 569 archived samples of AML patients (pts).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP891377.RAl-5W-rsVI1m1B_D3qwEWws1V6_NSInqTsACYFrjD9Zo130_assertion description "[In search for general PCR targets for minimal residual disease (MRD) studies in acute myeloid leukemia (AML), Wilms' tumor gene 1 (WT1) expression was assessed by real-time RT-PCR relative to the control gene ABL in 569 archived samples of AML patients (pts).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP891377.RAl-5W-rsVI1m1B_D3qwEWws1V6_NSInqTsACYFrjD9Zo130_provenance.
• assertion description "[In search for general PCR targets for minimal residual disease (MRD) studies in acute myeloid leukemia (AML), Wilms' tumor gene 1 (WT1) expression was assessed by real-time RT-PCR relative to the control gene ABL in 569 archived samples of AML patients (pts).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In search for general PCR targets for minimal residual disease (MRD) studies in acute myeloid leukemia (AML), Wilms' tumor gene 1 (WT1) expression was assessed by real-time RT-PCR relative to the control gene ABL in 569 archived samples of AML patients (pts).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP219283.RAcN3Q3YxVjguD1iV5kIZE5da_pRuC4tqmm6gZ8pT5pOQ130_assertion description "[In search for general PCR targets for minimal residual disease (MRD) studies in acute myeloid leukemia (AML), Wilms' tumor gene 1 (WT1) expression was assessed by real-time RT-PCR relative to the control gene ABL in 569 archived samples of AML patients (pts).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP219283.RAcN3Q3YxVjguD1iV5kIZE5da_pRuC4tqmm6gZ8pT5pOQ130_provenance.
• NP576991.RAabvJ5G5K-jNOWFfzjw8mz57iRqP5ceRY84pEYoVDr6k130_assertion description "[In search for general PCR targets for minimal residual disease (MRD) studies in acute myeloid leukemia (AML), Wilms' tumor gene 1 (WT1) expression was assessed by real-time RT-PCR relative to the control gene ABL in 569 archived samples of AML patients (pts).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP576991.RAabvJ5G5K-jNOWFfzjw8mz57iRqP5ceRY84pEYoVDr6k130_provenance.
• assertion description "[In search for general PCR targets for minimal residual disease (MRD) studies in acute myeloid leukemia (AML), Wilms' tumor gene 1 (WT1) expression was assessed by real-time RT-PCR relative to the control gene ABL in 569 archived samples of AML patients (pts).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In search for general PCR targets for minimal residual disease (MRD) studies in acute myeloid leukemia (AML), Wilms' tumor gene 1 (WT1) expression was assessed by real-time RT-PCR relative to the control gene ABL in 569 archived samples of AML patients (pts).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In search for general PCR targets for minimal residual disease (MRD) studies in acute myeloid leukemia (AML), Wilms' tumor gene 1 (WT1) expression was assessed by real-time RT-PCR relative to the control gene ABL in 569 archived samples of AML patients (pts).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP496701.RAU5IA5JxiE2nBO-ep-VwYtdEV4qhm39BnFLONg1ghWOg130_assertion description "[In search for general PCR targets for minimal residual disease (MRD) studies in acute myeloid leukemia (AML), Wilms' tumor gene 1 (WT1) expression was assessed by real-time RT-PCR relative to the control gene ABL in 569 archived samples of AML patients (pts).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP496701.RAU5IA5JxiE2nBO-ep-VwYtdEV4qhm39BnFLONg1ghWOg130_provenance.
• NP496703.RAc6Pzysk6lZDUtZcyOZMlLQL9YVIg9z313zoBci3bWqc130_assertion description "[In search for general PCR targets for minimal residual disease (MRD) studies in acute myeloid leukemia (AML), Wilms' tumor gene 1 (WT1) expression was assessed by real-time RT-PCR relative to the control gene ABL in 569 archived samples of AML patients (pts).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP496703.RAc6Pzysk6lZDUtZcyOZMlLQL9YVIg9z313zoBci3bWqc130_provenance.
• NP496704.RAX4VWcLdc4BwvP2qWxONBioSxC4o9mNeG2RuLBW1kyDM130_assertion description "[In search for general PCR targets for minimal residual disease (MRD) studies in acute myeloid leukemia (AML), Wilms' tumor gene 1 (WT1) expression was assessed by real-time RT-PCR relative to the control gene ABL in 569 archived samples of AML patients (pts).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP496704.RAX4VWcLdc4BwvP2qWxONBioSxC4o9mNeG2RuLBW1kyDM130_provenance.
• NP496707.RAgLqD-rCCfjXf0Z3tZPJ0obJHz5vh4ga37nrfh4yRFn4130_assertion description "[In search for general PCR targets for minimal residual disease (MRD) studies in acute myeloid leukemia (AML), Wilms' tumor gene 1 (WT1) expression was assessed by real-time RT-PCR relative to the control gene ABL in 569 archived samples of AML patients (pts).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP496707.RAgLqD-rCCfjXf0Z3tZPJ0obJHz5vh4ga37nrfh4yRFn4130_provenance.
• NP576951.RA5E32TNsewoKFmfjg1ZqZsUx06sU8xK73lsaE4LwsFew130_assertion description "[In search for general PCR targets for minimal residual disease (MRD) studies in acute myeloid leukemia (AML), Wilms' tumor gene 1 (WT1) expression was assessed by real-time RT-PCR relative to the control gene ABL in 569 archived samples of AML patients (pts).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP576951.RA5E32TNsewoKFmfjg1ZqZsUx06sU8xK73lsaE4LwsFew130_provenance.
• NP577029.RAzPeunqa6DaNWiRftDfRkq6LUOqiV4HGlskPjW_efBEM130_assertion description "[In search for general PCR targets for minimal residual disease (MRD) studies in acute myeloid leukemia (AML), Wilms' tumor gene 1 (WT1) expression was assessed by real-time RT-PCR relative to the control gene ABL in 569 archived samples of AML patients (pts).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP577029.RAzPeunqa6DaNWiRftDfRkq6LUOqiV4HGlskPjW_efBEM130_provenance.
• NP496699.RAMdJTN3ejD1sEEVHtvYWVHM5cpYHf5B1V1yL7Ux9Ti2M130_assertion description "[In search for general PCR targets for minimal residual disease (MRD) studies in acute myeloid leukemia (AML), Wilms' tumor gene 1 (WT1) expression was assessed by real-time RT-PCR relative to the control gene ABL in 569 archived samples of AML patients (pts).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP496699.RAMdJTN3ejD1sEEVHtvYWVHM5cpYHf5B1V1yL7Ux9Ti2M130_provenance.
• NP496705.RAPIVIVAvULJb_us00BuAHulsfO_Pg6I4VFLzPbPaTcxU130_assertion description "[In search for general PCR targets for minimal residual disease (MRD) studies in acute myeloid leukemia (AML), Wilms' tumor gene 1 (WT1) expression was assessed by real-time RT-PCR relative to the control gene ABL in 569 archived samples of AML patients (pts).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP496705.RAPIVIVAvULJb_us00BuAHulsfO_Pg6I4VFLzPbPaTcxU130_provenance.